June 2007:
June 29th:
Halcygen Pharmaceuticals Lists On ASX With 20% premium
read article >
June 26th:
Benitec Launches New Website: Better Investor Communications
read article >
June 26th:
HealthLinx Aims For Profitable Stand-alone High-tech Business With New Fee-For-Service Business To Find Valuable Food And Drug Ingredients
read article >
June 21st:
Halcygen's $12.5m IPO Closes Oversubscribed
read article >
June 21st:
Acrux's Estradiol Spray For Menopause Symptoms To Be Marketed In Australia By Aspen Pharmacare
read article >
June 20th:
Benitec Appoints New Scientific Advisory Board Renowned Worldwide Experts In Gene Silencinga
read article >
June 19th:
Stem Cell Sciences In-Licenses Breakthrough Discovery For The Production Of Human Stem Cells
read article >
June 19th:
HealthLinx Announces Appointment Of Director
read article >
June 15th:
Biosignal CEO Resigns
read article >
June 14th:
Rockeby Signs Letter of Intent With Sandoz To Market Pepp Hangover Remedy In China
read article >
June 14th:
Portland Orthopaedics' May Sales Up 23%
read article >
June 14th:
Genepharm Boosts Generic Drug Range To 95 Percent
read article >
June 13th:
Genepharm Appoints My Chemist GM As Chief Operations Office
read article >
June 13th:
Benitec Commences HIV Study In Humans In Los Angeles
read article >
June 12th:
Portland Orthopaedics' First M-COR Implanted Into An Australian Recipient
read article >
June 12th:
ChemGenex Confirms Activity of Ceflatonin in T315I-Positive CML®
read article >
June 6th:
Portland Orthopaedics Receives Regulatory Approval M-COR Primary Hip Sales To Commence In Australia
read article >
June 4th:
Pharmaxis' Aridol Gains European Approval, Asthma Product Approved In 14 Countries Across Europe
read article >
|
